In silico identification of Histone Deacetylase inhibitors using Streamlined Masked Transformer-based Pretrained features.

Histone Deacetylases (HDACs) are enzymes that regulate gene expression by removing acetyl groups from histones. They are involved in various diseases, including neurodegenerative, cardiovascular, inflammatory, and metabolic disorders, as well as fibrosis in the liver, lungs, and kidneys. Successfully identifying potent HDAC inhibitors may offer a promising approach to treating these diseases.